N
nference
Artificial intelligence to synthesize the exponentially growing biomedical knowledge
About nference
nference.ai is a health technology startup that leverages artificial intelligence (AI) to transform unstructured data from electronic medical records (EMR) into actionable insights for the healthcare industry. The company operates in the health tech market, serving clients such as top health systems and biopharmaceutical companies, including Mayo Clinic, Duke Health, Banner Health, and Vanderbilt University Medical Center.
The business model of nference.ai revolves around partnering with these health systems to access their vast and rich EMR data, which includes clinical notes, images, lab results, and more. This data is then processed and analyzed using state-of-the-art AI technology and deep biomedical expertise to create powerful software solutions. These solutions aim to enable scientists to discover and develop personalized diagnostics and treatments for patients worldwide, thereby making significant strides in human health.
One of the key offerings of nference.ai is its federated clinical analytics platform. This platform is built through partnerships with top health systems and is designed to unlock the value of multimodal EMR data. The company also works with sequencing partners to provide clinical-grade whole exome and transcriptome sequencing for patients at partner centers.
nference.ai generates revenue by providing these software solutions and services to its clients. The company's recent achievement includes receiving U.S. FDA 510(k) clearance for its ECG-AI Algorithm to detect low ejection fraction, demonstrating its commitment to advancing healthcare through technology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Cambridge, United States
- Employees
- 317
- Open positions
- None listed
- Dealroom signal
- 61.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Electronic Health Records (EHR), Predictive Analytics, Biotechnology, Drug Development, Biomarkers, Neurology, Genetics and genomics, Core AI, Precision Medicine, Immune System, Genome Engineering
- Business model
- SaaS
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Dec 2022 | $0 | — | PharmStars | ↗ |
| SERIES COther financing | Dec 2020 | $60M | $240M | Mayo Clinic · Matrix Capital Limited · Matrix Capital Management · Matrix Partners | — |
Growth signals
Latest recorded traffic for nference is 13K monthly website visits, up 170.8% over the last three months. nference's team declined 7.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Matrix Partners
Matrix Capital Management
Series A3 investors entered at this stage
Mayo Clinic Business Development
NTT Venture Capital
Mayo Clinic
Series B and later1 investor entered at this stage
Matrix Capital Limited
Other known investors1 additional known investor
PharmStars
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about nference on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See nference’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.